MPR1d
Low-Dose Atropine Eye Drops Under Review for Pediatric Myopia
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
Myopia is a disease, not a refractive error. Here's what that means
Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This ...
Healio4d
FDA accepts new drug application for SYD-101 to treat pediatric myopia progression
The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...
Ophthalmology Times4d
FDA accepts new drug application for low-dose atropine from Sydnexis
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Optometry Advisor10d
In Modern Myopia Management, Optometrists Have The Tools, The Talent, And The Evidence
With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...
Journal of Nuclear Medicine Technology13d
Recognizing and Responding to the Acute Cardiac Stress Patient
A cardiac emergency in SPECT/CT and PET/CT occurs infrequently but necessitates prompt recognition and an appropriate ...
Pandemic or Poison? The deadly mystery striking fear into a tiny village
The crisis began on December 7, 2024, when 40-year-old Fazal Hussain, his wife, and their four children suddenly fell ill after attending a wedding. They suffered from severe stomach pain, vomiting, ...